ORBIMED ADVISORS LLC – Cullinan Oncology, Inc. Transaction History
ORBIMED ADVISORS LLC portfolio value:
$8.17M
portfolio value
Cullinan Oncology, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -4.99% | -33.5K shares | -429K | $12.82 | 637.28K |
| Q2 2022 | share | 0.00% | 0 shares | 1.57M | $12.82 | 670.78K | |
| Q1 2022 | share | Decrease | -16.68% | -134.25K shares | -5.39M | $10.47 | 670.78K |
| Q4 2021 | share | Decrease | -29.76% | -341.10K shares | -13.44M | $15.7 | 805.04K |
| Q3 2021 | share | 0.00% | 0 shares | -3.64M | $22.57 | 1.14M | |
| Q2 2021 | share | 0.00% | 0 shares | -18.24M | $25.75 | 1.14M | |
| Q1 2021 | share | Increase | 0.00% | 1.14M shares | 47.76M | $41.67 | 1.14M |